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Abstract
Background: Mechanical thrombectomy was approved by NICE as a treatment for stroke in 2016. However, most
of the evidence is from studies conducted during working hours. Only few centres in the UK perform
thrombectomies out-of-hours. The Royal Stoke University Hospital (RSUH) has offered thrombectomies over 24 h
(24/7) since 2010. The aim of this service review is to compare the outcomes for patients treated in regular working
hours to those treated outside normal working hours within this unit.
Methods: This retrospective service analysis includes all patients treated with mechanical thrombectomy at RSUH
since the start of the service in January 2010 to June 2019. Data on key demographics, timings, procedural
complications, and long-term outcomes including death and disability at 90 days were collected. In-hours was
defined as the time between 8:00–17:00 h, Monday to Friday; out-of-hours was defined as any time outside this
period.
Results: In total, 516 mechanical thrombectomies were performed in this time period; data were available on 501
of these. Successful recanalization (TICI 2b/3) was achieved in 86% of patients. By 90 days 96 (19%) had died and
234 (47%) were functionally independent (modified Rankin Scale score ≤ 2). 211 (42%) of the procedures were
performed in-hours and 290 (58%) out-of-hours. Door-to-CT and door-to-groin times were significantly longer out-
of-hours than in-hours, but thrombectomy duration was significantly shorter. There were no significant differences
in complications and short- and long-term outcomes.
Conclusion: Mechanical thrombectomy was delivered safely and effectively 24/7 in this UK hospital, with no
difference in clinical outcomes.
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Background
The development of mechanical thrombectomy has rev-
olutionized the treatment of large-vessel occlusive
stroke. In patients presenting up to 6 h from stroke on-
set, mechanical thrombectomy improves the absolute
rate of functional independence by approximately 20%,
compared to best medical therapy [1]. It has been ap-
proved by the National Institute for Health and Care Ex-
cellence (NICE) in 2016 [2]. Recent trials have
demonstrated that perfusion imaging can increase the
time window for mechanical thrombectomy to up to 24
h in selected patients [3, 4]. It is estimated that around
10% of stroke patients may benefit from mechanical
thrombectomy, representing approximately 10,000 pa-
tients a year in the UK alone [5].
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Delivering mechanical thrombectomy services to eli-
gible patient populations has proven challenging. In the
UK, a scarcity of experienced operators, lack of existing
infrastructure and geographical limitations have severely
hampered service delivery [6]. As such, mechanical
thrombectomy is only provided at a limited number of
specialist neuroscience centres and mostly within normal
working hours or on an ad hoc basis. The paucity of 24-
h (24/7) UK thrombectomy centres has contributed to
the UK falling behind internationally in the provision of
mechanical thrombectomy. In a 6-month period in 2018,
just 478 mechanical thrombectomies were performed in
the UK, compared to over 9000 in Germany and over
4500 in France [7].
The Royal Stoke University Hospital (RSUH) was the
first UK centre to perform mechanical thrombectomy
for ischaemic stroke on a regular basis and the first to
deliver this 24/7. A review of the service performed in
2014 demonstrated endovascular therapy-based services
could be safely and effectively delivered in a UK setting,
with nearly 50% of patients having a favorable outcome
[8]. Thrombectomy was conducted 24/7 from the outset,
with ad hoc availability of staff in the first few years, and
a formal rota since 2016. While all staff are on site in-
hours, out-of-hours the stroke physician, the radiog-
rapher, the theatre nurse, and the neurointerventionist
have to travel in. Anaesthesia is covered by a consultant
neuroanaesthetist in the day, and the registrar on call
with consultant back-up out-of-hours. The aim of this
study was to establish whether, in the context of the
current service offered, there are differences in thromb-
ectomy outcomes for patients admitted to RSUH within
normal working hours compared to with those admitted
outside normal working hours.
Methods
A service review was undertaken of all patients who
were treated with mechanical thrombectomy for large-
vessel occlusive stroke between the start of January 2010
and the end of June 2019 at RSUH, a large comprehen-
sive stroke centre in the West Midlands (UK) admitting
about 1200 stroke patients per year from the local popu-
lation and as transfers for neurointervention. Data were
extracted from a prospective database of all patients who
receive mechanical thrombectomy. In total 516 mechan-
ical thrombectomy procedures were performed in this
time period; key data were missing in 15 of these pa-
tients, leaving 501 included in the complete analysis.
Data extracted included: age, sex, stroke severity
assessed by the National Institutes for Health Stroke
Scale (NIHSS) at onset, risk factors for stroke, use of
thrombolytic agents, anaesthetic strategy, affected vessel,
timings, post-procedural complications, and disability,
assessed by the modified Rankin Scale (mRS) at 90 days.
For patients who were intubated or in coma, a NIHSS of
35 was assigned. Death was recorded as a NIHSS of 42
(the highest numerical score on the scale) and an mRS
score of 6.
Background characteristics and the NIHSS were
assessed on admission by either a consultant stroke
physician or a stroke nurse. All formal imaging was re-
ported by a consultant neuroradiologist. The mRS score
at 90 days and post-procedure complications were
assessed over the phone or in person by a consultant
stroke physician or an advanced nurse practitioner. Oc-
clusion location was defined as most proximal occlusion
present on digital subtraction angiography. Symptomatic
intracranial haemorrhage was defined using Safe Imple-
mentation of Thrombolysis in Stroke Monitoring Study
(SITSMOST) criteria as a local or remote parenchymal
haemorrhage type 2 on the 22–36 h post-treatment head
scan, combined with a neurological deterioration of four
or more points from the lowest NIHSS within 24 h or
leading to death [9]. Malignant cerebral oedema was de-
fined as cerebral oedema causing midline shift with asso-
ciated clinical deterioration of 4 or more NIHSS points.
Groin haematoma was defined as a haematoma requir-
ing medical intervention, including blood transfusion or
fibrin injection.
In-hours admission was defined as between 8:00–17:00
from Monday to Friday, excluding public holidays. This
was chosen as the time period where the full stroke,
interventional and neuroanaesthetic teams are present
on the hospital site. Patients admitted outside this time
window were classified as an out-of-hours admission.
For those patients who suffered a stroke whilst an in-
patient at RSUH, onset time was used to determine
whether the stroke was in-hours or out-of-hours.
Statistics
Demographic and clinical characteristics of patients were
summarized through frequencies and percentages or
means and standard deviations. As this is a service re-
view, for the purpose of statistical testing the population
was defined as past and future stroke patients admitted
to RSUH, rather than the broader population of stroke
patients in the UK. The assumptions of all statistical
analyses were checked. Baseline comparisons were made
through unrelated t tests for numerical variables and
through Pearson chi-square tests for binary variables.
Comparisons of procedural factors and short- and long-
term outcomes were made between in-hours and out-of-
hours patients in a multivariable statistical model,
controlling for baseline demographic and clinical
characteristics (see Table 1). Numerical outcomes were
analysed through analysis of covariance, with differences
expressed as mean differences, and binary outcomes
through multivariable logistic regression, with
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differences expressed as odds ratios (ORs). The OR
indicates the increase or decrease in the odds of an
outcome for a one-unit increase in the predictor vari-
able (e.g. moving from female to male, or an add-
itional year of age). In this instance, an OR greater
than 1 indicates that the outcome was more likely
among in-hours patients than among out-of-hours pa-
tients, and an OR less than 1 that it was less likely.
Statistical significance was set at p ≤ 0.05 (two-tailed)
and 95% confidence intervals (CIs) were calculated for
between group estimates. No correction was made for
multiple testing.
In addition to the main comparison between in-hours
and out-of-hours, two exploratory analyses were con-
ducted: between day (08:00–21:59) and night (22:00–07:
59) and between weekday and weekend. These compari-
sons are presented with 95% CIs, but hypothesis tests
were not conducted in view of the exploratory nature of
these analyses (see supplementary tables).
As this was a service review, patients and the public
were not involved in the design, conduct, reporting, or
dissemination plans.
Results
Demographics
In total, 501 patients treated with mechanical thrombec-
tomy between 2010 and 2019 were analysed (Table 1). Of
these patients, the majority were treated outside of normal
working hours, with 290 (58%) treated in this time period
and 211 (42%) treated in-hours (detailed breakdown in
Fig. 1). The mean age of included patients was 66.7 (stand-
ard deviation [SD] 13.7), and 262 (52%) were male. Most
strokes were severe, with a mean (SD) NIHSS score of
18.3 (7.0) and median of 18.0. The majority (89%) affected
the anterior circulation. Patients admitted out-of-hours
were significantly younger and more likely to have a prior
diagnosis of hypertension than those admitted in-hours.
There were no other significant differences in demo-
graphic or clinical characteristics between the two groups.
Timings
The mean time from hospital admission (door) to the
end of the thrombectomy was 205 min with a mean 34
min time lapse between door and computed tomography
(CT) of the head, a mean of 113 min between CT and
Table 1 Baseline demographic and clinical details
Total (n = 501) In-hours (n = 211) Out-of-hours (n = 290) p value*
Age: mean (SD) 66.7 (13.7) 68.6 (12.6) 65.3 (14.2) 0.008
Sex: n (%) males 262 (52.3) 100 (47.4) 162 (55.9) 0.061
Hypertension: n (%) 252 (50.3) 93 (54.8) 159 (44.1) 0.017
Atrial fibrillation: n (%) 140 (27.9) 56 (26.5) 84 (29.0) 0.550
Hyperlipidaemia: n (%) 134 (26.7) 56 (26.5) 78 (26.9) 0.929
Diabetes: n (%) 80 (16.0) 29 (13.7) 51 (17.6) 0.246
Previous stroke/TIA: n (%) 76 (15.2) 31 (14.7) 45 (15.5) 0.799
Coma pre procedure: n (%) 17 (3.4) 7 (3.3) 10 (3.4) 0.936
Thrombolysis: n (%) 368 (73.5) 155 (73.5) 213 (73.4) 0.998
NIHSS at onset: median; mean (SD) 18.0; 18.3 (7.0) 18.0; 18.1 (7.1) 18.0; 18.4 (6.9) 0.718
Anterior circulation lesion: n (%) 447 (89.2) 189 (89.6) 258 (89.0) 0.828**
CCA: n (%) 6 (1.2) 4 (1.9) 2 (0.7)
ICA: n (%) 158 (31.5) 64 (30.3) 94 (32.4)
ACA: n (%) 1 (0.2) 1 (0.5) 0 (0.0)
M1: n (%) 239 (47.7) 98 (46.4) 141 (48.6)
M2: n (%) 37 (7.4) 19 (9.0) 18 (6.2)
M3: n (%) 6 (1.2) 3 (1.4) 3 (1.0)
Posterior circulation lesion: n (%) 54 (10.8) 22 (10.4) 32 (11.0)
Vertebral artery: n (%) 4 (0.8) 2 (0.9) 2 (0.7)
Basilar artery: n (%) 47 (9.4) 18 (8.5) 29 (10.0)
PCA: n (%) 3 (0.6) 2 (0.9) 1 (0.3)
ACA anterior cerebral artery, CCA common carotid artery, ICA internal carotid artery, TIA transient ischaemic attack, M1, M2, M3 middle cerebral artery segments 1,
2 and 3, NIHSS National Institutes for Health Stroke Scale, PCA posterior cerebral artery, SD standard deviation
* p values are derived from an unrelated t test for continuous variables and a Pearson chi-square test for nominal variables
** p value for a comparison across groups of anterior versus posterior circulation lesions
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start of the procedure (groin time defined as femoral ar-
tery puncture) and a mean procedure duration of 64 min
(Table 2). Patients admitted during working hours had a
significantly lower door-to-CT time, resulting in a corre-
sponding lower door-to-groin time. Patients presenting
out-of-hours had a significantly reduced procedure time,
but there was no significant difference in door-to-
procedure-end-times between the two groups.
Table S2 shows the estimates in respect of the explora-
tory comparisons between day and night and weekday
and weekend.
Procedural factors
Details of the procedure are shown in Table 3. Advanced
imaging (CT perfusion) was used in 11% of cases. The
majority of cases (74%) were conducted under general
Fig. 1 Flowchart showing number of patients treated in-hours vs out of hours, day vs night and weekend vs weekday
Table 2 Timelines from onset to completion of the procedure
Total (n = 501) In-hours (n = 211)* Out-of-hours (n = 290)* Adjusted mean difference (95% CI); p value**
Onset to door:
median; mean (SD)
108.0; 172.1 (195.1) 109.0; 169.8 (192.4) 107.0; 173.9 (197.5) −2.6 (−37.2, 32.1); .884
Door to CT***:
median; mean (SD)
23.0; 34.1 (45.4) 21.0; 26.3 (22.7) 24.0; 40.0 (56.4) 14.9 (6.7, 23.2); <.001
CT to groin***:
median; mean (SD)
104.5; 113.0 (63.6) 89.5; 108.6 (71.8) 111.0; 116.3 (56.6) 8.7 (−3.0, 20.4); .143
Procedure time:
median; mean (SD)
55.0; 63.8 (42.5) 60.0; 69.5 (44.0) 53.0; 59.6 (40.9) −10.8 (− 18.5, −3.2); .006
Door to groin:
median; mean (SD)
124.0; 138.2 (85.5) 110.0; 124.9 (73.7) 135.5; 148.0 (92.1) 25.6 (11.3, 39.9); <.001
Door to procedure end:
median; mean (SD)
184.0; 204.9 (105.4) 181.0; 196.5 (93.0) 188.5; 211.1 (113.4) 16.4 (−1.7, 34.4); .075
CI confidence interval, SD standard deviation
End of procedure is defined as the time of the final intracranial angiogram
* Denominators differ between variables owing to missing or not applicable values
** Out-of-hours minus in-hours; a positive difference indicates time was greater for out-of-hours. Adjusted for age, sex, hypertension, atrial fibrillation,
hyperlipidaemia, diabetes mellitus, previous stroke/TIA, coma, NIHSS at onset, anterior/posterior circulation lesion
*** In total 40 patients were transferred straight to the neurointervention suite and received no imaging at RSUH prior to thrombectomy
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anaesthesia. Recanalization was successful (thrombolysis
in cerebral infarction (TICI) score of 2b or 3) in 86% of
cases, and was achieved at first pass in 45% of cases. CT
perfusion (OR = 2.49) and successful recanalization
(OR = 1.93) were more likely in-hours than out-of-hours,
but first-pass recanalization (OR = 0.64) was less likely.
Other differences were non-significant.
Table S3 shows the estimates in respect of the explora-
tory comparisons between day and night and weekday
and weekend. Differences in in-hospital timelines some-
what more pronounced with longer delays for all steps
at night compared with the primary analysis (in hours vs
out of hours), while differences were less marked in the
weekday vs weekend comparison.
Long- and short-term outcomes
Outcomes and complications up to 90 days are shown in
Table 4. Eight patients (2%) had a symptomatic intrace-
rebral haemorrhage (SITS criteria). At 90 days 234 (47%)
were independent in activities of daily living (mRS ≤ 2).
Short- and long-term outcomes did not differ signifi-
cantly between the two groups, though the low number
of events in some of the binary variables means that the
statistical comparisons would have low power and atten-
tion should be focused on the magnitude of the
differences.
With respect specifically to mortality at 90 days,
there was no significant difference between in-hours
and out-of-hours (Table 4). The significant
predictors of mortality within this analysis were age
(OR = 1.04), NIHSS at onset (OR = 1.12), diabetes
(OR = 2.60), thrombolysis (OR = 0.53), posterior cir-
culation lesion (OR = 2.51); p ≤ .024 in each case.
The goodness of fit for the model (Nagelkerke
pseudo-R2) was .234.
Table S4 shows the estimates in respect of the explora-
tory comparisons between day and night and weekday
and weekend.
Table 3 Details of the procedure
Total (n = 501) In-hours (n = 211) Out-of-hours (n = 290) Adjusted odds ratio (95% CI); p value*
CT perfusion: n (%) 56 (11.2) 35 (16.6) 21 (7.2) 2.49 (1.36, 4.54); .003
General anaesthetic: n (%) 371 (74.1) 158 (77.1) 213 (77.2) 1.08 (0.69, 1.70); .744
Successful recanalization: n (%) 431 (86.0) 188 (90.4) 243 (85.3) 1.93 (1.07, 3.50); .030
First pass recanalization: n (%) 223 (44.5) 83 (42.1) 140 (53.2) 0.64 (0.43, 0.94); .023
Intracranial vasospasm: n (%) 7 (1.4) 3 (1.4) 4 (1.4) 1.37 (0.28, 6.85); .699
Dissection: n (%) 33 (6.6) 18 (8.6) 15 (5.3) 1.92 (0.91, 4.03); 086
Percentages are valid percentages (based on non-missing values) Successful recanalization was defined as a thrombolysis in cerebral infarction (TICI) score of 2b
or 3. An odds ratio greater than 1 indicates that the outcome was more likely among in-hours patients than among out-of-hours patients, and an odds ratio less
than 1 that it was less likely
* Out-of-hours as reference category. Adjusted for age, sex, hypertension, atrial fibrillation, hyperlipidaemia, diabetes mellitus, previous stroke/TIA, coma, NIHSS at
onset, anterior/posterior circulation lesion
Table 4 Complications and outcomes up to 90 days
Total (n = 501) In-hours (n = 211) Out-of-hours (n = 290) Adjusted difference (95% CI); p value*
NIHSS at 1 week: median; mean (SD) 7.0; 13.0 (14.0) 6.0; 12.1 (13.0) 7.0; 13.7 (14.6) 1.2 (− 1.2, 3.5); .334
Renal failure; n (%) 8 (1.6) 4 (1.9) 4 (1.4) 1.06 (0.22, 4.98); .946
Groin haematoma: n (%) 8 (1.6) 5 (2.4) 3 (1.0) 1.93 (0.43, 8.65); .392
Malignant middle cerebral artery syndrome: n (%) 44 (8.8) 12 (5.7) 32 (11.1) 0.52 (0.24, 1.14); .102
Hemicraniectomy: n (%) 13 (2.6) 5 (2.4) 8 (2.8) 1.42 (0.37, 5.44); .606
Symptomatic intracerebral haemorrhage: n (%) 8 (1.6) 3 (1.4) 5 (1.7) 0.85 (0.19, 3.73); .827
Subarachnoid haemorrhage: n (%) 45 (9.0) 22 (10.9) 23 (8.2) 1.28 (0.68, 2.41); .449
Deep vein thrombosis within 90 days: n (%) 12 (2.4) 7 (3.3) 5 (1.7) 1.95 (0.57, 6.64); .287
Pulmonary embolism within 90 days: n (%) 15 (3.0) 7 (3.3) 8 (2.8) 1.45 (0.48, 4.34); .509
Stroke within 90 days: n (%) 10 (2.0) 2 (1.0) 8 (2.8) 0.36 (0.07, 1.78); .210
Death at 90 days: n (%) 96 (19.2) 34 (16.1) 62 (21.4) 0.61 (0.36, 1.02); .061
Functional independence at 90 days: n (%) 234 (46.7) 100 (47.4) 134 (46.2) 1.07 (0.72, 1.58); .746
Percentages are valid percentages (based on non-missing values). Functional independence is defined as modified Rankin Scale score of 0–2. Symptomatic
intracerebral haemorrhage is defined as per the SITS-MOST criteria
* Difference expressed as odds ratio, with out-of-hours as reference category, except for NIHSS, where it is mean difference (out-of-hours minus in-hours).
Adjusted for age, sex, hypertension, atrial fibrillation, hyperlipidaemia, diabetes mellitus, previous stroke/TIA, coma, NIHSS at onset, anterior/posterior
circulation lesion
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Year by year
Comparison of cases performed, timings and outcomes
on a year-by-year basis are shown in Table 5. Service de-
mand at RSUH has increased significantly over the 10-
year period analysed, from 18 cases in 2010 to 86 in
2018. Mean door-to-groin times show a trend of im-
provement from 190min in 2010 to 127 min in 2019.
Trends in relation to death at 90 days and functional in-
dependence at 90 days are less clear.
Comparison to the Swift prime trial
A cohort of patient from our database who met the
SWIFT PRIME trial entry requirements were identified
(Table 6). Patients eligible for SWIFT PRIME in our
dataset had a similar mortality (11% vs 9%) and func-
tional independence (59% vs 60%) rate to those treated
in the original trial [10].
Discussion
In this service review of over 500 patients treated with
mechanical thrombectomy we have demonstrated that a
24/7 mechanical thrombectomy service can be delivered
safely and effectively in this comprehensive stroke centre
in a UK NHS hospital, with no significant difference in
short- or long-term outcomes for patients admitted in-
hours versus out-of-hours. This includes rates of
functional independence and death at 90 days, early
post-procedural complications, and symptomatic
intracerebral haemorrhage. However, patients admitted
out-of-hours had significantly longer door-to-groin
times, with delays at all points of the treatment pathway
contributing to this effect. Procedure times were, how-
ever, shorter for out-of-hours patients.
A previous service review conducted at RSUH of 106
stroke patients treated between 2009 and 2013 demon-
strated that endovascular therapy could be delivered
safely and effectively within this UK setting [8]. Since
this was published many changes have occurred in
mechanical thrombectomy, with the publication of the
landmark positive randomized controlled trials in
2015 [11] and the use of CT perfusion software in
assessing the extent of the viable penumbra in late
presenters [3, 4]. This has greatly expanded the de-
mand for mechanical thrombectomy at our unit, with
86 mechanical thrombectomies performed in 2018
compared to 18 in 2010.
In trials establishing mechanical thrombectomy as a
viable treatment for acute ischaemic stroke, there was
little impact on rate of death in comparison to best med-
ical therapy [11]. Our study reported an overall mortality
of 19% at 90 days, which is higher than the 15% reported
in our previous service review [8], with similar rates of
functional independence at 90 days: 48% then versus
47% now. The difference in mortality is likely due to
changes in patient selection (mean age 64 years then and
66.8 years now), with increasing age being significantly
associated with mortality at 90 days in our multiple lo-
gistic regression analysis.
There are no published national data for 90-day out-
comes after thrombectomy, making it difficult to gauge
how our hospital’s performance compares with others in
the UK. A recent service review from the Walton Centre
in Liverpool showed a 33% mortality after thrombec-
tomy; however, this review only analysed 48 patients in
total [12]. Data from the mechanical thrombectomy
service at the Royal Victoria Hospital Belfast showed an
overall mortality rate of 22%, of 214 patients treated
between 2014 and 2017 [13]. A meta-analysis of 8
thrombectomy RCTs in 2015 showed a mortality of 16%
[14], and in the more recent 5 large RCTs using modern
devices mortality ranged from 9 to 21% [1]. Mortality in
the 33 patients in the thrombectomy group in the UK
PISTE RCT was 21%. Only 147 patients treated at our
centre over the 10-year time period would be eligible for
Table 5 Year-by-year comparison
Year Cases (n = 501) Death at 90 days
(n = 96); n (%)
Functional independence at
90 days (n = 234); n (%)
Door to groin timings;
median; mean (SD)
2010 18 2 (11.1) 9 (50.0) 162.5; 190.3 (112.7)
2011 27 2 (7.4) 17 (63.0) 135.0; 141.7 (55.6)
2012 40 7 (17.5) 15 (37.5) 142.5; 143.9 (74.8)
2013 53 7 (13.2) 24 (45.3) 127.0; 154.9 (113.8)
2014 44 12 (27.3) 17 (38.6) 136.0; 149.0 (74.3)
2015 58 14 (24.1) 31 (53.4) 122.5; 137.9 (84.4)
2016 68 15 (22.1) 35 (51.5) 114.0; 126.6 (81.9)
2017 60 12 (20.0) 31 (51.7) 108.0; 131.2 (107.3)
2018 86 15 (17.4) 39 (45.3) 118.0; 128.5 (72.3)
2019 (to June) 47 10 (21.3) 16 (34.0) 118.0; 127.0 (58.3)
SD standard deviation
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thrombectomy under SWIFT PRIME criteria. Those
who did undergo thrombectomy had a similar mortality
rate to those in the original trial (11% vs 9%) [10]. Be-
cause of these more stringent inclusion criteria, mortal-
ity in RCTs tends to be lower than in unselected clinical
cases.
A recent whole-country review of thrombectomy ser-
vices in Germany between 2015 and 2018 found a mor-
tality rate of 29% and a functional independence rate of
37% at 90 days [15]. These findings are most likely a re-
sult of inclusion of high-risk patients – such as those
with basilar artery occlusions, significant co-morbidities,
or higher initial mRS scores –combined with an increase
in treatment of patients with more borderline inclusion
criteria.
Ischaemic stroke occurrence shows a diurnal variation,
with the majority of strokes occurring in the morning
between 9:00 am and noon [16]. However, a recent study
from the USA showed that the most common time for
mechanical thrombectomy to be performed was in the
evening between 21:00 and 22:00, with 58.7% of mech-
anical thrombectomies performed outside of normal
working hours [17]. This was similar to our data, where
the majority of mechanical thrombectomies were per-
formed out-of-hours. Currently in the UK, few centres
offer a 24/7 service for mechanical thrombectomy, po-
tentially excluding a large number of eligible patients
who may benefit from this procedure.
Despite the possibility of treating patients up to 24 h
post stroke onset with CT perfusion, the adage ‘time is
brain’ still remains true. This makes minimizing door-
to-groin times essential for improving long-term
functional outcomes. Additionally, this metric acts as a
surrogate marker of effective service delivery. In our pre-
vious service review only door-to-procedure-end time
was recorded; on this composite metric we have signifi-
cantly improved with a median reduction of over 60
min. Our median door-to-groin times are, at 124 min,
better than the UK national average (149 min) in the
2018/19 data cut of the UK National Sentinel Stroke
Audit [18], but considerably slower than the 64 min in a
national audit of stroke care in the Netherlands [19].
Long door-to-groin times out-of-hours have been re-
ported at other centres. Two recent studies of in-hours
and out-of-hours thrombectomy from the United States
[20] and Germany [21] reported similar delays in door-
to-groin times (21 min and 20min respectively), but also
found worse early [21] and late [20] outcomes in pa-
tients treated out-of-hours. In contrast, another study
from Germany, with no delay in door-to-groin time out-
of-hours, found no difference in early or late outcomes
following mechanical thrombectomy [22]. Outcomes
were no different in- and out-of-hours in our hospital.
This may be because delays in the early part of the path-
way (door-to-groin) were compensated by more rapid
procedure times at night.
On reviewing the exploratory analyses, differences in
pathway timings were identified on comparison between
day versus night; and weekend versus weekday, suggest-
ing pathway delays were not limited to a specific time
period. These pathway delays did not lead to major dif-
ferences in long or short term outcomes.
This is the largest report of thrombectomy outcomes
from a single centre in the UK, with a well-established
service dating back to 2010 [8]. Our database demon-
strated a high rate of follow-up and differences in base-
line demographic and clinical characteristics were
controlled for in the statistical analysis, thereby remov-
ing potential biasing of the in-hours versus out-of-hours
comparisons. Limitations are that there were changes in
the thrombectomy pathway in our hospital and in eligi-
bility criteria for thrombectomy over the time period,
with the development of a hub and spoke model with
more remote transfers over time, and more extensive
use of advanced imaging and inclusion of patients up to
24 h after onset during the final 2 years.
Conclusion
Demand for mechanical thrombectomy procedures has
increased dramatically over the past few years. Expand-
ing evidence from randomized controlled trials has
greatly contributed to this increase, and as the evidence
continues to evolve, further increases in demand are ex-
pected. We have presented a service analysis of the lon-
gest running 24/7 mechanical thrombectomy service in
the UK and analysed the effect of admission time on
overall outcomes. The results of our study show that
thrombectomy can be provided safely and effectively
Table 6 Swift prime trial comparison
Royal Stoke University Hospital (n = 501) Swift Prime trial
Total eligible 142 98
Mortality at 90 days 15 (11%) 9 (9%)
Functional independence at 90 days 85 (59%) 59 (60%)
Number of patients eligible for treatment if the Swift-Prime trial inclusion criteria had been applied and outcomes at 90 days. Eligibility of 142 patients was based
upon: age > 18 and < 80 (n = 423); NIHSS > 8 and < 30 (n = 422); intravenous tissue plasminogen activator given (n = 368); internal carotid artery or middle cerebral
artery segment 1 occlusion (n = 397); onset to procedure end < 6 h (n = 294)
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out-of-hours in our hospital, when fewer staff are on
site. Further improvements could be made in our centre
by speeding up the CT-to-groin time. This may require
a service redesign.
Rolling out thrombectomy for extended hours, and
eventually 24/7 nationally, will be a key step in address-
ing this shortfall in service provision in the UK.
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